Estimated Impact of the US COVID-19 Vaccination Campaign-Getting to 94% of Deaths Prevented
JAMA Netw Open
.
2022 Jul 1;5(7):e2220391.
doi: 10.1001/jamanetworkopen.2022.20391.
Authors
Malia Jones
1
,
Karim Khader
2
3
,
Westyn Branch-Elliman
4
5
6
Affiliations
1
Applied Population Laboratory, Department of Community and Environmental Sociology, University of Wisconsin, Madison.
2
IDEAS Center of Innovation, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah.
3
Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.
4
Section of Infectious Diseases, Department of Medicine, Veterans Affairs (VA) Boston Healthcare System, Boston, Massachusetts.
5
Center for Healthcare Organization and Implementation Research, VA Boston Healthcare System, Boston, Massachusetts.
6
Department of Medicine, Harvard Medical School, Boston, Massachusetts.
PMID:
35793090
PMCID:
PMC9531754
DOI:
10.1001/jamanetworkopen.2022.20391
No abstract available
Publication types
Comment
MeSH terms
COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
Mass Vaccination
Substances
COVID-19 Vaccines
Grants and funding
K01 AI132741/AI/NIAID NIH HHS/United States
P2C HD047873/HD/NICHD NIH HHS/United States